Clinical trial for Ovary Cancer
Official title Multimedia Aid for Genetic Testing in Gynecologic Oncology
ClinicalTrials.gov ID: NCT07084168
What this study is testing
- What it's testing
- The study wants to see if showing patients short videos about genetic testing changes how often doctors order tests and refer patients to genetics.
- Who it's for
- Women who have been diagnosed with ovarian or endometrial cancer.
- What's involved
- Participants will watch one of three videos that explain genetic testing for their cancer type and can fill out a short satisfaction survey. Researchers will then review medical charts to see how many tests were ordered and referrals made before and after the videos.
- Time commitment
- The study involves a single video session and a brief survey, with follow‑up chart review; it lasts only a few weeks.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- In order to participate in this study, a subject must meet all of the eligibility criteria outlined below.
- Reviewed informed consent to participate in the study.
- Subject is willing and able to comply with study procedures based on the judgment of the investigator.
- Age ≥ 18 years at the time of consent.
- Diagnosis of ovarian cancer or endometrial cancer
You likely can't join if
- Previously completed genetic testing
- Did not receive initial cancer-directed treatment at study site
See the full eligibility criteria
- In order to participate in this study, a subject must meet all of the eligibility criteria outlined below.
- Reviewed informed consent to participate in the study.
- Subject is willing and able to comply with study procedures based on the judgment of the investigator.
- Age ≥ 18 years at the time of consent.
- Diagnosis of ovarian cancer or endometrial cancer
- Eligible for genetic testing
- English or Spanish is the primary language
- Previously completed genetic testing
- Did not receive initial cancer-directed treatment at study site
The study team makes the final eligibility decision.
Where it is enrolling
- Chapel Hill, North Carolina, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Chapel Hill, North Carolina, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.